Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina.

Trial Profile

Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Capadenoson (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 24 Apr 2014 Last checked against ClinicalTrials.gov record.
    • 14 Aug 2008 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 14 Aug 2008 Planned initiation date changed from 1 Oct 2007 to 1 Dec 2007 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top